Amin Naseem

CIK 00016467542 companiesDUBLIN 2, L2

SEC Profile

Transactions

Companies

Filings

CIK

0001646754

Recent Transactions

27 trades

Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−11,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2026-02-12$21.00/sh−22,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−49,500→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−11,000→ 0 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2025-07-29+11,000→ 22,000 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2025-07-29+11,000→ 11,000 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2024-07-30+11,000→ 11,000 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2024-07-30+11,000→ 11,000 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2024-05-17+49,500→ 49,500 total
Award
Bellerophon Therapeutics, Inc.
Common Stock
2023-06-07+47,578→ 291,865 total
Award
Bellerophon Therapeutics, Inc.
Common Stock
2023-02-10+84,000→ 244,287 total
Award
Bellerophon Therapeutics, Inc.
Stock Options (right to buy)
2021-12-31$3.10/sh+8,671→ 23,809 total
Award
Bellerophon Therapeutics, Inc.
Common Stock
2021-12-31+39,032→ 160,287 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2020-09-10$10.12/sh+6,509→ 15,138 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2019-09-26+46,266→ 109,482 total
Purchase
Bellerophon Therapeutics, Inc.
Common Stock
2019-01-25$0.70/sh+571,429→ 1,818,867 total
Award
Bellerophon Therapeutics, Inc.
Common Stock
2018-06-21+17,124→ 1,247,438 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2018-06-05$2.27/sh+38,216→ 83,216 total
Purchase
Bellerophon Therapeutics, Inc.
Common Stock Warrants (right to buy)
2017-09-29+456,432→ 456,432 total
Purchase
Bellerophon Therapeutics, Inc.
Common Stock
2017-09-29+456,432→ 1,230,314 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2017-09-22+10,000→ 10,000 total
Award
Bellerophon Therapeutics, Inc.
Common Stock
2017-06-28+36,232→ 773,882 total
Purchase
Bellerophon Therapeutics, Inc.
Common Stock Warrants (right to buy)
2016-11-29+714,285→ 714,285 total
Purchase
Bellerophon Therapeutics, Inc.
Common Stock
2016-11-29+714,285→ 737,650 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2016-06-17+10,000→ 10,000 total
Award
Bellerophon Therapeutics, Inc.
Common Stock
2016-04-28+23,365→ 23,365 total
Award
Bellerophon Therapeutics, Inc.
Stock Option (right to buy)
2015-06-29+25,000→ 25,000 total

Companies

Recent Filings

Address

C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE

DUBLIN 2, L2, D02 T380

View on SEC.gov